Investors & Partners

Who we are

Celosia Therapeutics is a biotechnology company developing precision gene therapies for neurodegenerative diseases, including ALS and FTD.

Built on decades of neuroscience research, our work focuses on targeting the underlying genetic and cellular drivers of disease, with the goal of modifying the neuronal microenvironment to halt, reverse and defeat neurodegenerative disease.

Company highlights

Our programs

Celosia have various programs focused on key disease drivers across neurodegenerative conditions.

Clinical Pipeline